PT -期刊文章盟e . m . Frohman AU - d s Goodin盟p·a·卡拉布雷西AU - j . r . Corboy AU - p . k . Coyle AU - m .菲利皮主持AU - j·a·弗兰克AU - s . l . Galetta AU - r。格罗斯曼盟- k小贩盟- n . j . Kachuck盟——m·c·莱文盟——j·t·菲利普斯AU - m . k . Racke盟——v·m·里维拉盟——w·h·斯图尔特TI - MRI的效用(退休)援助——10.1212/01. wnl.0000082654.99838女士怀疑。EF DP - 2003 9月09年TA -神经病首页学第六PG - 602 - 611 - 61 IP - 5 4099 - //www.ez-admanager.com/content/61/5/602.short 4100 - //www.ez-admanager.com/content/61/5/602.full所以Neurology2003 09年9月;61 AB -成像技术的发展和新发展的治疗提供更有效的管理战略的承诺直到最近,女士确认女士的诊断通常需要临床活动的示范中传播的时间和空间。然而,随着磁共振成像技术的出现,神秘的疾病活动可以在50 - 80%的患者在临床表现。Prospective studies have shown that the presence of such lesions predicts future conversion to clinically definite (CD) MS. Indeed, in a young to middle-aged adult with a clinically isolated syndrome (CIS), once alternative diagnoses are excluded at baseline, the finding of three or more white matter lesions on a T2-weighted MRI scan (especially if one of these lesions is located in the periventricular region) is a very sensitive predictor (>80%) of the subsequent development of CDMS within the next 7 to 10 years. Moreover, the presence of two or more gadolinium (Gd)-enhancing lesions at baseline and the appearance of either new T2 lesions or new Gd enhancement on follow-up scans are also highly predictive of the subsequent development of CDMS in the near term. By contrast, normal results on MRI at the time of clinical presentation makes the future development of CDMS considerably less likely.